ADELMAN BURT A

Insider Buys Quantity –
3
2022-05-12PurchaseVerve Therapeutics, Inc.
VERV
20,000
0.0403%
$12.15$243,052+72.88%
2022-03-15PurchaseVerve Therapeutics, Inc.
VERV
8,000
0.0168%
$21.38$171,070+5.1%
2021-12-02PurchaseVerve Therapeutics, Inc.
VERV
director
9,400
0.0333%
$31.34$294,607-15.06%
2007-10-15SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
60,500
0.0203%
$82.00$4.96M-26.4%
2007-08-30SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
46,000
0.0121%
$49.03$2.26M-3.51%
2007-08-27SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
8,750
0.0021%
$43.50$380,625-0.92%
2007-08-17SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
28,750
0.01%
$60.46$1.74M+4.15%
2007-07-26SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
115,000
0.0408%
$59.61$6.86M+7.11%
2007-07-25SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
29,000
0.0085%
$50.15$1.45M+5.61%
2007-07-03SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
10,225
0.0029%
$44.24$452,354+13.13%
2007-03-20SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
6,634
0.0019%
$44.48$295,073+31.6%
2007-02-13SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
11,871
0.0035%
$49.22$584,243+15.8%
2006-09-19SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
18,348
0.0054%
$42.75$784,329+14.13%
2006-01-03SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
57,500
0.0122%
$33.60$1.93M-2.31%
2005-12-28SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
20,500
0.0023%
$16.90$346,450+0.97%
2005-09-28SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
20,500
0.0061%
$38.39$787,086+17.35%
2005-06-28SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
20,500
0.0061%
$34.26$702,369+29.54%
2005-01-03SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
20,500
0.0062%
$67.03$1.37M-40.44%
2004-12-27SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
12,593
0.0006%
$9.67$121,774-39.77%
2004-09-27SaleBiogen Inc.
BIIB
EVP, Portfolio Strategy
12,592
0.0006%
$9.67$121,765-31.04%